GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diagnos Inc (OTCPK:DGNOF) » Definitions » Gross-Profit-to-Asset %

DGNOF (Diagnos) Gross-Profit-to-Asset % : -58.89% (As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Diagnos Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Diagnos's annualized Gross Profit for the quarter that ended in Sep. 2024 was $-0.86 Mil. Diagnos's average Total Assets over the quarter that ended in Sep. 2024 was $1.45 Mil. Therefore, Diagnos's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 was -58.89%.


Diagnos Gross-Profit-to-Asset % Historical Data

The historical data trend for Diagnos's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnos Gross-Profit-to-Asset % Chart

Diagnos Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.61 -16.81 -23.84 -24.63 -113.37

Diagnos Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.35 -89.56 -115.41 -40.09 -58.89

Competitive Comparison of Diagnos's Gross-Profit-to-Asset %

For the Health Information Services subindustry, Diagnos's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnos's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Diagnos's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Diagnos's Gross-Profit-to-Asset % falls into.



Diagnos Gross-Profit-to-Asset % Calculation

Diagnos's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Mar. 2024 )/( (Total Assets (A: Mar. 2023 )+Total Assets (A: Mar. 2024 ))/ count )
=-0.619/( (0.601+0.491)/ 2 )
=-0.619/0.546
=-113.37 %

Diagnos's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-0.856/( (0.806+2.101)/ 2 )
=-0.856/1.4535
=-58.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Diagnos Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Diagnos's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Diagnos Business Description

Traded in Other Exchanges
Address
7005 Taschereau Boulevard, Suite 265, Brossard, Longueuil, QC, CAN, J4Z 1A7
Diagnos Inc is engaged in the provision of software-based interpretation services to assist health specialists in the detection of diabetic retinopathy. The company provides image analysis services through CARA (Computer Assisted Retinal Analysis). It operates in the business segment of Healthcare services. The company has a business presence in Canada, the United States, Mexico, Chile, and others. The company's key revenue is derived from Canada.